-Managing Director and Principal Consultant
-Boutique consultancy focusing on life sciences strategy, due diligence and valuation

▪ Lead analyst for European biopharmaceutical stocks (UCB, Ipsen, Lundbeck,
Genmab, Galapagos) with IPO experience (Polyphor)
▪ Focus on pharmaceutical market access, pricing and reimbursement; authored the
team’s most widely read thematic publications
▪ Developed drug sales forecasting and stock segmentation methodologies,
incorporating the paradigm of pharmaceutical market access (budget impact,
affordability, payer hurdles, patient consumerism, etc.)

▪ Developed and implemented marketing strategies for three inline brands, achieving
outstanding year-over-year volume-driven sales growth
▪ Led cross-functional launch teams (marketing, medical affairs, market access, health
economics, regulatory affairs) for two pipeline products
▪ Conceived a patient support program (AMGENcareTM) that was subsequently rolled
out to other therapeutic areas and European countries
▪ Affiliate digital strategy lead
▪ Job rotation as sales representative

▪ Advanced cross-functional strategic planning, e.g., established scenario planning
▪ Worked with the International Strategy Committee towards defining strategic priorities and resource allocation across brands and countries
▪ Led cross-functional strategic and operational projects: implemented a commercial excellence initiative and developed a systematic approach

Pharma strategy projects in Europe and the US, e.g.
▪ Global market entry and launch strategy for a biologic drug
▪ Innovative pharma-payer partnerships and contracting models in Germany
▪ Rx-to-OTC switch in the UK: strategy development and implementation preparation

Primarily strategy projects in Europe, e.g.
▪ Biotech company and pharmaceutical R&D services provider: full potential program
▪ Consumer and industrial goods: portfolio transparency and optimisation
▪ Consumer electronics: development of a health and wellbeing strategy